1. Birkmayer W, Hornykiewicz O (1961) Der L-3,4-Dihydroxyphenylalanin (= Dopa)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73: 787–789
2. Bittkau S, Przuntek H (1986) Psychosis and the lisuride pump. Lancet 2: 349 (letter)
3. Burns RS, Calne DB (1983) Disposition of dopaminergic ergot compounds following oral administration. In: Calne DB, Horowski R, McDonald RJ, Wuttke W (eds) Lisuride and other dopamine agonists. Raven Press, New York, pp 153–160
4. Critchley P, Grandas Perez F, Quinn N, Coleman P, Parkes D, Marsden CD (1986) Psychosis and the lisuride pump. Lancet 2: 349 (letter)
5. Dorow R, Graf KJ, Nieuweboer B, Horowski R (1980) Intravenous lisuride: a new tool for testing responsiveness to dopamine agonists and neuroendocrine function. Acta Endocrinol [Suppl] (Copenh) 234: 9